ADVERSE REACTION |
PLACEBO (N=59) % |
DDAVP 20 µg (N=60) % |
DDAVP 40 µg (N=61) % |
BODY AS A WHOLE
Abdominal Pain
|
0
|
2
|
2
|
Asthenia
|
0
|
0
|
2
|
Chills
|
0
|
0
|
2
|
Headache
|
0
|
2
|
5
|
Throat Pain
|
2
|
0
|
0
|
NERVOUS SYSTEM
Depression
|
2
|
0
|
0
|
Dizziness
|
0
|
0
|
3
|
RESPIRATORY SYSTEM
Epistaxis
|
2
|
3
|
0
|
Nostril Pain
|
0
|
2
|
0
|
Respiratory Infection
|
2
|
0
|
0
|
Rhinitis
|
2
|
8
|
3
|
CARDIOVASCULAR SYSTEM
Vasodilation
|
2
|
0
|
0
|
DIGESTIVE SYSTEM
Gastrointestinal Disorder
|
0
|
2
|
0
|
Nausea
|
0
|
0
|
2
|
SKIN & APPENDAGES
Leg Rash
|
2
|
0
|
0
|
Rash
|
2
|
0
|
0
|
SPECIAL SENSES
Conjunctivitis
|
0
|
2
|
0
|
Edema Eyes
|
0
|
2
|
0
|
Lachrymation Disorder
|
0
|
0
|
2
|